352 related articles for article (PubMed ID: 29734463)
1. Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People.
Pang Y; Kartsonaki C; Turnbull I; Guo Y; Clarke R; Chen Y; Bragg F; Yang L; Bian Z; Millwood IY; Hao J; Han X; Zang Y; Chen J; Li L; Holmes MV; Chen Z
Hepatology; 2018 Oct; 68(4):1308-1318. PubMed ID: 29734463
[TBL] [Abstract][Full Text] [Related]
2. Diabetes, plasma glucose and incidence of colorectal cancer in Chinese adults: a prospective study of 0.5 million people.
Pang Y; Kartsonaki C; Guo Y; Chen Y; Yang L; Bian Z; Bragg F; Millwood IY; Shen L; Zhou S; Liu J; Chen J; Li L; Holmes MV; Chen Z
J Epidemiol Community Health; 2018 Oct; 72(10):919-925. PubMed ID: 29970599
[TBL] [Abstract][Full Text] [Related]
3. Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies.
Pang Y; Kartsonaki C; Guo Y; Bragg F; Yang L; Bian Z; Chen Y; Iona A; Millwood IY; Lv J; Yu C; Chen J; Li L; Holmes MV; Chen Z
Int J Cancer; 2017 Apr; 140(8):1781-1788. PubMed ID: 28063165
[TBL] [Abstract][Full Text] [Related]
4. Random plasma glucose levels and cause-specific mortality among Chinese adults without known diabetes: an 11-year prospective study of 450,000 people.
Vermunt J; Bragg F; Halsey J; Yang L; Chen Y; Guo Y; Du H; Meng F; Pei P; Yu C; Lv J; Chen J; Li L; Lewington S; Chen Z;
BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34728472
[TBL] [Abstract][Full Text] [Related]
5. Alcohol drinking and risks of liver cancer and non-neoplastic chronic liver diseases in China: a 10-year prospective study of 0.5 million adults.
Im PK; Millwood IY; Kartsonaki C; Guo Y; Chen Y; Turnbull I; Yu C; Du H; Pei P; Lv J; Walters RG; Li L; Yang L; Chen Z;
BMC Med; 2021 Sep; 19(1):216. PubMed ID: 34530818
[TBL] [Abstract][Full Text] [Related]
6. The Natural History of NAFLD, a Community-Based Study at a Large Health Care Delivery System in the United States.
Nyberg LM; Cheetham TC; Patton HM; Yang SJ; Chiang KM; Caparosa SL; Stern JA; Nyberg AH
Hepatol Commun; 2021 Jan; 5(1):83-96. PubMed ID: 33437903
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus.
Han X; Zhang X; Liu Z; Fan H; Guo C; Wang H; Gu Y; Zhang T
J Diabetes; 2024 May; 16(5):e13564. PubMed ID: 38664879
[TBL] [Abstract][Full Text] [Related]
8. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.
Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM
Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613
[TBL] [Abstract][Full Text] [Related]
9. Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study.
Zou Y; Yu M; Sheng G
Lipids Health Dis; 2020 Jun; 19(1):145. PubMed ID: 32563249
[TBL] [Abstract][Full Text] [Related]
10. Adiposity in relation to risks of fatty liver, cirrhosis and liver cancer: a prospective study of 0.5 million Chinese adults.
Pang Y; Kartsonaki C; Turnbull I; Guo Y; Chen Y; Clarke R; Bian Z; Bragg F; Millwood IY; Yang L; Huang Y; Yang Y; Zhang X; Chen J; Li L; Holmes MV; Chen Z
Sci Rep; 2019 Jan; 9(1):785. PubMed ID: 30692555
[TBL] [Abstract][Full Text] [Related]
11. Self-Reported Primary Cooking Fuels Use and Risk of Chronic Digestive Diseases: A Prospective Cohort Study of 0.5 Million Chinese Adults.
Wen Q; Liu T; Yu Y; Zhang Y; Yang Y; Zheng R; Li L; Chen R; Wang S
Environ Health Perspect; 2023 Apr; 131(4):47002. PubMed ID: 37011136
[TBL] [Abstract][Full Text] [Related]
12. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.
Liang Y; Chen H; Liu Y; Hou X; Wei L; Bao Y; Yang C; Zong G; Wu J; Jia W
J Clin Endocrinol Metab; 2022 Jan; 107(1):88-97. PubMed ID: 34508601
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study.
Joo EJ; Chang Y; Yeom JS; Ryu S
Hepatology; 2017 Mar; 65(3):828-835. PubMed ID: 28035771
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission.
Wild SH; Walker JJ; Morling JR; McAllister DA; Colhoun HM; Farran B; McGurnaghan S; McCrimmon R; Read SH; Sattar N; Byrne CD;
Diabetes Care; 2018 Feb; 41(2):341-347. PubMed ID: 29167212
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in the association between socioeconomic status and diabetes prevalence and incidence in China: cross-sectional and prospective studies of 0.5 million adults.
Wu H; Bragg F; Yang L; Du H; Guo Y; Jackson CA; Zhu S; Yu C; Luk AOY; Chan JCN; Gasevic D; Li L; Chen Z; Wild SH
Diabetologia; 2019 Aug; 62(8):1420-1429. PubMed ID: 31152186
[TBL] [Abstract][Full Text] [Related]
17. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
[TBL] [Abstract][Full Text] [Related]
18. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.
Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Waterworth DM; Kendrick S; Sattar N; Alazawi W
BMC Med; 2019 May; 17(1):95. PubMed ID: 31104631
[TBL] [Abstract][Full Text] [Related]
19. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
[TBL] [Abstract][Full Text] [Related]
20. Higher ultra-processed food intake is associated with adverse liver outcomes: a prospective cohort study of UK Biobank participants.
Zhao L; Clay-Gilmour A; Zhang J; Zhang X; Steck SE
Am J Clin Nutr; 2024 Jan; 119(1):49-57. PubMed ID: 37871746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
